Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
Age-related macular degeneration (AMD) is a growing public health concern given the aging population and it is the leading cause of blindness in developed countries, affecting individuals over the age of 55 years. AMD affects the retinal pigment epithelium (RPE) and Bruch’s membrane in the macula, l...
Κύριοι συγγραφείς: | Borchert, GA, Shamsnajafabadi, H, Ng, BWJ, Xue, K, De Silva, SR, Downes, SM, MacLaren, RE, Cehajic-Kapetanovic, J |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Frontiers Media
2024
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
ανά: Grace A. Borchert, κ.ά.
Έκδοση: (2024-07-01) -
The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
ανά: Grace A. Borchert, κ.ά.
Έκδοση: (2023-08-01) -
Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances
ανά: Michelle E. McClements, κ.ά.
Έκδοση: (2020-11-01) -
Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
ανά: Borchert, GA, κ.ά.
Έκδοση: (2024) -
Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy
ανά: Hoda Shamsnajafabadi, κ.ά.
Έκδοση: (2023-08-01)